Table 1.
Correlation of CCDC60 mRNA expression and clinical prognosis in head and neck squamous cell carcinoma with different clinicopathological factors by Kaplan–Meier plotter.
| Clinicopathological characteristics | Overall survival | Relapse-free survival | ||||
|---|---|---|---|---|---|---|
| N | Hazard ratio | P | N | Hazard ratio | P | |
| Sex | ||||||
| Female | 164 | 0.76 (0.45 - 1.28) | 0.3014 | 94 | 0.55 (0.18 - 1.64) | 0.2764 |
| Male | 445 | 0.56 (0.38 - 0.82) | 0.0024 | 94 | 1.58 (0.54 - 4.6) | 0.3959 |
| Race | ||||||
| White | 526 | 0.57 (0.41 - 0.8) | 0.0011 | 133 | 0.58 (0.25 - 1.31) | 0.1831 |
| Asian | 11 | – | – | 4 | – | – |
| Black/African America | 74 | 0.66 (0.27 - 1.66) | 0.3794 | 5 | – | – |
| Stage | ||||||
| 1 | 50 | 0.23 (0.02 - 2.26) | 0.1711 | 66 | 4.06 (0.74 - 22.3) | 0.082 |
| 2 | 91 | 2.43 (1.03 - 5.71) | 0.0355 | 57 | 0.19 (0.03 - 1.12) | 0.0393 |
| 3 | 98 | 0.46 (0.21 - 0.99) | 0.0416 | 49 | 1.92 (0.5 - 7.44) | 0.3356 |
| 4 | 308 | 0.48 (0.31 - 0.75) | 0.001 | 0 | – | – |
| Grade | ||||||
| 1 | 84 | 0.41 (0.09 - 1.85) | 0.2334 | 36 | 4.56 (0.81 - 25.7) | 0.0608 |
| 2 | 340 | 0.69 (0.45 - 1.05) | 0.0798 | 78 | 0.37 (0.13 - 1.07) | 0.0571 |
| 3 | 158 | 0.43 (0.23 - 0.8) | 0.0058 | 49 | 0.23 (0.03 - 1.92) | 0.1381 |
| 4 | 7 | – | – | 1 | – | – |
| Mutation burden | ||||||
| High | 307 | 0.76 (0.51 - 1.15) | 0.1978 | 99 | 0.5 (0.11 - 2.4) | 0.3811 |
| Low | 296 | 0.53 (0.35 - 0.79) | 0.0019 | 89 | 0.49 (0.19 - 1.25) | 0.1262 |
Bold values indicate p < 0.05. –, None.